Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1459241010 | Oral gum (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1479325013 | Oral gum | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2660330012 | Oral gum (qualifier value) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3635975010 | Prolonged-release oral gum (dose form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3635976011 | Prolonged-release oral gum | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Medicated chewing-gum | Is a | False | Prolonged-release oral gum | Inferred relationship | Existential restriction modifier | |
| Aspirin 227.5mg gum tablet | Has manufactured dose form | False | Prolonged-release oral gum | Inferred relationship | Existential restriction modifier | |
| Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 chewing gum prolonged-release oral gum (clinical drug) | Has manufactured dose form | True | Prolonged-release oral gum | Inferred relationship | Existential restriction modifier | |
| Product containing precisely nicotine (as nicotine polacrilex) 4 milligram/1 chewing gum prolonged-release oral gum (clinical drug) | Has manufactured dose form | True | Prolonged-release oral gum | Inferred relationship | Existential restriction modifier | |
| Aspirin 227.5mg prolonged-release oral gum | Has manufactured dose form | False | Prolonged-release oral gum | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR